http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101953142-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate | 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101953142-B1 |
| titleOfInvention | Thickened Eye Drop Composition Comprising Polydeoxyribonucleotide and Method Thereof |
| abstract | The present invention relates to a viscous eye drop containing a polydeoxyribonucleotide and a method for producing the same, and is characterized by adding a cationic polymer to increase the viscosity. The viscous eye drop composition of the present invention is safe in the body using polydeoxyribonucleotide which is a biocomponent component and osmotic pressure is not excessively increased, so that it is possible to keep suitability when used as an eye drop, have. In addition, there is an effect of maximizing the effectiveness of the drug by improving the disadvantage that the drug retention property is low due to the low viscosity of the conventional eyedrops. |
| priorityDate | 2012-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.